Benign neoplasm: Aortic body and other paraganglia

CD2_BENIGN_AORTICBODY_PARAGANGLIA

adenoma: The congenital absence of the thyroid gland.

Endpoint definition

FinnGen phenotype data

392423 individuals

diagram downward connector

Apply sex-specific rule None

392423

diagram downward connector

Check conditions None

392423

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 D35.6&
Hospital discharge: ICD-9 2276
Cause of death: ICD-10 D35.6&
Cause of death: ICD-9 2276

2 out of 7 registries used, show all original rules.

21

diagram downward connector

Check minimum number of events None

21

diagram downward connector

Include endpoints None

21

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

21

diagram downward connector
CD2_BENIGN_AORTICBODY_PARAGANGLIA

Control definitions

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2
Parent code in ICD-10 D35
Name in latin Neoplasma benignum glomeris aortici

Similar endpoints

List of similar endpoints to Benign neoplasm: Aortic body and other paraganglia based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Broader endpoints:

Venn diagram with a set fully inside an highlighted set Narrower endpoints:

Show all endpoint correlations

Summary Statistics

Key figures

All Female Male
Number of individuals 21 15 6
Unadjusted prevalence (%) 0.01 0.01 0.00
Mean age at first event (years) 45.62 42.69 52.94

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: CD2_BENIGN_AORTICBODY_PARAGANGLIA – Benign neoplasm: Aortic body and other paraganglia
GWS hits:

Survival analyses between endpoints

Not a core endpoint, no data to show.

Drugs most likely to be purchased after Benign neoplasm: Aortic body and other paraganglia

Endpoint not on priority list, no data to show.